Trials / Unknown
UnknownNCT05609448
MRI-guided Holmium-166 Radioembolization
Real-time MR Imaged Treatment With Holmium Microspheres of Patients With Primary Liver Cancer; a Single Center, Interventional, Non-randomized, Feasibility Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and feasibility of a personalized Ho-166-PLLA-MS TARE approach by using MRI guidance in inoperable patients with HCC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | MRI-guided radioembolization | Catheter placement will be performed using fluoroscopy, after which patients are transferred to the MRI scanner, where holmium microspheres are administered based on MRI dosimetry. Thereby, patients get a personalized dose administration. |
Timeline
- Start date
- 2023-05-23
- Primary completion
- 2025-01-01
- Completion
- 2025-10-01
- First posted
- 2022-11-08
- Last updated
- 2023-11-18
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05609448. Inclusion in this directory is not an endorsement.